- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.06. | SCHOTT Pharma Expands Vial Production in Lebanon, PA | ||
| 03.06. | Ashland Life Sciences Strengthens Presence in Asia Pacific | ||
| 03.06. | Cellares, TScan Partner to Automate Manufacture of TCR-T Candidate | ||
| 03.06. | Lonza Enhances Biologics Preclinical Development Offering | ||
| 03.06. | Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic | ||
| 02.06. | West Appoints Michel Lagarde a President and CEO | ||
| 02.06. | Dow, Univar Solutions Sign Agreement to Distribute Low-Carbon Products | ||
| 02.06. | Aragen to Manufacture Renaissance Pharma's Fast Track mAb | ||
| 02.06. | Evotec Appoints Rui Wang as EVP, Head of Global In Silico and AI | ||
| 01.06. | Intravacc, Primrose Bio Renew Partnership Enhancing Conjugate Vaccine Development | ||
| 01.06. | T-CURX Acquires Pantherna Therapeutics to Boost Clinical Validation of In-Vivo CAR-T Therapies | ||
| 01.06. | IL Group Introduces SMCL Series RC-506E Single Minute Changeover Labeler | ||
| 01.06. | Servier Agrees to Acquire Muscular Dystrophy Business of Edgewise Therapeutics | ||
| 01.06. | Ardena Names Dr. Ariane de Ganck as Chief Scientific Officer | ||
| 01.06. | Haisco, Lilly Strike Drug Development Deal | ||
| 01.06. | Circio, GenAssist Partner on AAV Gene Therapy | ||
| 29.05. | Natera, Diakonos Oncology Pair to Test Molecular Response in Refractory Melanoma Patients | ||
| 29.05. | Ratio Therapeutics Expands Manufacturing Collaboration with PharmaLogic | ||
| 29.05. | AstraZeneca's Imfinzi Approved by FDA for BCG-Naïve Non-Muscle-Invasive Bladder Cancer | ||
| 29.05. | Samsung Bioepis Launches OPUVIZ Biosimilar in Europe | ||
| 29.05. | Pfizer, Innovent Strike $10.5 Billion Oncology Deal to Develop 12 Cancer Medicines | ||
| 28.05. | PharmaEssentia Names Eric Vogel US Head of Commercialization Prior to Potential Drug Launch | ||
| 28.05. | Syncell Discovery Services Launches, Powered by Proprietary Platform | ||
| 28.05. | Thermo Fisher Launches E-Gel Power Snap Lite System | ||
| 28.05. | AI-Designed Drug Enters Phase I Trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.